Clinical Trials for Swedish Orphan Biovitrum

Explore 22 clinical trials worldwide

Showing 1-22 of 22 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Swedish Orphan Biovitrum

Clinical Trials (22)

NCT07148947
Pacritinib With Standard of Care Azacitidine or Decitabine as a Bridge to Allogeneic Hematopoietic Stem Cell Transplant for Patients With Accelerated and Blast Phase Myeloproliferative Neoplasms
PHASE2Not yet recruiting
27 participants
Started: Feb 1, 2026 · Completed: Dec 31, 2028
2 conditions2 sponsors1 location
NCT06227429
A Non-interventional, Post-Marketing Study to Describe Outcome of Nitisinone Treatment in HT-1 Patients
N/ARecruiting
15 participants
Started: Sep 30, 2025 · Completed: Jun 30, 2027
1 condition1 sponsor4 locations
NCT06666335
A Study to Evaluate Efficacy and Safety of Anakinra in Chinese Patients With Colchicine-resistent FMF
PHASE4Not yet recruiting
3 participants
Started: Sep 1, 2025 · Completed: Nov 30, 2027
1 condition2 sponsors0 locations
NCT06992505
Assessment of Macrophage Activation syndromE in STill's Disease in Italy
N/ARecruiting
35 participants
Started: Jun 6, 2025 · Completed: Sep 30, 2025
3 conditions1 sponsor2 locations
NCT06782373
A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)
PHASE2Recruiting
78 participants
Started: May 28, 2025 · Completed: Aug 31, 2027
2 conditions2 sponsors40 locations
NCT06940830
Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Efanesoctocog Alfa
PHASE4Recruiting
250 participants
Started: May 21, 2025 · Completed: Dec 31, 2028
1 condition2 sponsors21 locations
NCT06716814
Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa
PHASE3Recruiting
104 participants
Started: Mar 6, 2025 · Completed: Mar 31, 2027
1 condition2 sponsors22 locations
NCT06579144
Pharmacokinetic Comparison of Efanesoctocog Alfa vs Other EHL-rFVIII Products in Participants With Severe Haemophilia A
PHASE1Recruiting
24 participants
Started: Feb 24, 2025 · Completed: Oct 28, 2025
1 condition2 sponsors7 locations
NCT06538181
Pacritinib in Vacuoles, E1 Ubiqutin-activating Enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) Syndrome
PHASE1Recruiting
15 participants
Started: Feb 13, 2025 · Completed: Feb 28, 2029
3 conditions2 sponsors1 location
NCT06752850
A Study to Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa Prophylaxis
PHASE4Recruiting
35 participants
Started: Dec 19, 2024 · Completed: Dec 31, 2026
6 conditions2 sponsors10 locations
NCT06550141
Emapalumab Prevention of CAR-T Cell Associated Toxicities
PHASE2Recruiting
28 participants
Started: Sep 18, 2024 · Completed: Aug 1, 2027
7 conditions2 sponsors2 locations
NCT06352216
Prevalence of Synovitis in Patients With Haemophilia A
N/ARecruiting
300 participants
Started: Apr 15, 2024 · Completed: Mar 31, 2027
4 conditions2 sponsors1 location
NCT05772546
Avatrombopag vs. Placebo for CIT in GI Malignancies
PHASE2Recruiting
60 participants
Started: Nov 1, 2023 · Completed: Jul 31, 2026
3 conditions2 sponsors4 locations
NCT04656184
A Trial Comparing the Efficacy and Safety of Anakinra Versus Intravenous Immunoglobulin (IVIG) Retreatment, in Patients With Kawasaki Disease Who Failed to Respond to Initial Standard IVIG Treatment
PHASE3Recruiting
84 participants
Started: Oct 20, 2023 · Completed: Mar 31, 2027
1 condition2 sponsors1 location
NCT05817812
A Study Evaluating Physical Activity and Joint Health in Severe Haemophilia A Patients ≥12 Years Treated Once Weekly With Efanesoctocog Alfa
PHASE3Active, not recruiting
93 participants
Started: Jul 31, 2023 · Completed: Jun 12, 2026
1 condition2 sponsors30 locations
NCT05776472
A Real World Effectiveness Study of Pegcetacoplan in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
N/ARecruiting
200 participants
Started: Jun 26, 2023 · Completed: Aug 15, 2029
1 condition2 sponsors75 locations
NCT05814159
A Study of Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD)
PHASE3Active, not recruiting
15 participants
Started: Aug 24, 2022 · Completed: Jun 24, 2026
2 conditions2 sponsors8 locations
NCT05152238
ITP Registry and Accompanying Biospecimen Collection
N/ARecruiting
1,100 participants
Started: Nov 29, 2021 · Completed: Apr 30, 2027
1 condition7 sponsors64 locations
NCT04293523
A 48-Month Study to Evaluate Long-Term Effectiveness of Elocta on Joint Health
N/AActive, not recruiting
427 participants
Started: Mar 30, 2020 · Completed: Apr 30, 2026
1 condition1 sponsor53 locations
NCT03587701
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
PHASE2Recruiting
57 participants
Started: Jan 3, 2019 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT03165734
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
PHASE3Recruiting
399 participants
Started: Jun 26, 2017 · Completed: Jul 30, 2027
3 conditions2 sponsors207 locations
NCT01746849
Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation
PHASE2Active, not recruiting
82 participants
Started: Dec 31, 2012 · Completed: Dec 31, 2025
4 conditions2 sponsors1 location